1/5/24 16:51 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -566 | 29.46 | 0 | -19 | -2 | 905 | D | | | | | | | | | | | | | | |
1/3/24 17:30 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 924 | D | | | | | | | | | | | | | | |
1/6/23 17:32 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -248 | 37.21 | 0 | -7 | -1 | 825 | D | | | | | | | | | | | | | | |
1/4/23 20:36 | 1/1/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 832 | D | | | | | | | | | | | | | | |
3/4/22 21:07 | 1/1/22 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 824 | D | | | | | | | | | | | | | | |
3/4/22 21:07 | 1/1/22 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -280 | 112.26 | 0 | -2 | 0 | 824 | D | | | | | | | | | | | | | | |
9/1/21 20:21 | 8/30/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.dm | 2,071 | 17.06 | 0 | 121 | 18 | 778 | D | | | | | | | | | | | | | | |
9/1/21 20:21 | 8/30/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.dm | -19,520 | 160.83 | 0 | -121 | -13 | 778 | D | | | | | | | | | | | | | | |
8/25/21 16:14 | 8/23/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 364 | 13.40 | 0 | 27 | 4 | 778 | D | | | | | | | | | | | | | | |
8/25/21 16:14 | 8/23/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -4,125 | 152.01 | 0 | -27 | -3 | 778 | D | | | | | | | | | | | | | | |
8/20/21 18:14 | 8/19/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 304 | 13.40 | 0 | 23 | 3 | 778 | D | | | | | | | | | | | | | | |
8/20/21 18:14 | 8/19/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S.d | -3,431 | 151.28 | 0 | -23 | -3 | 778 | D | | | | | | | | | | | | | | |